Both are equally important. It’s not a yes or no question. The science and evidence are there to prove that this HIV prevention strategy works. We would be doing our communities a huge disservice if we didn’t try to simultaneously prevent and treat HIV.
Ethical questions around access, affordability, and distribution are ones we are trying to address with partners at the local, state, and federal levels. Advocates are committed to investing in ending AIDS—which prioritizes making sure all people living with HIV have access to HIV treatment and also that HIV-negative people have access to use the tools they need to prevent them from getting infected in the first place.